IBDEI08N ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11428,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,11428,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,11428,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,11429,0)
 ;;=224.7^^55^620^28
 ;;^UTILITY(U,$J,358.3,11429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11429,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,11429,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,11429,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,11430,0)
 ;;=237.70^^55^620^66
 ;;^UTILITY(U,$J,358.3,11430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11430,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,11430,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,11430,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,11431,0)
 ;;=239.6^^55^620^65
 ;;^UTILITY(U,$J,358.3,11431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11431,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,11431,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,11431,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,11432,0)
 ;;=239.81^^55^620^97
 ;;^UTILITY(U,$J,358.3,11432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11432,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,11432,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,11432,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,11433,0)
 ;;=272.0^^55^620^48
 ;;^UTILITY(U,$J,358.3,11433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11433,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,11433,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,11433,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,11434,0)
 ;;=340.^^55^620^63
 ;;^UTILITY(U,$J,358.3,11434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11434,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,11434,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,11434,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,11435,0)
 ;;=345.90^^55^620^29
 ;;^UTILITY(U,$J,358.3,11435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11435,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,11435,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,11435,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,11436,0)
 ;;=368.02^^55^620^23
 ;;^UTILITY(U,$J,358.3,11436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11436,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,11436,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,11436,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,11437,0)
 ;;=368.11^^55^620^103
 ;;^UTILITY(U,$J,358.3,11437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11437,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,11437,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,11437,2)
 ;;=^268831
 ;;^UTILITY(U,$J,358.3,11438,0)
 ;;=368.59^^55^620^11
 ;;^UTILITY(U,$J,358.3,11438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11438,1,3,0)
 ;;=3^Color Blindness
 ;;^UTILITY(U,$J,358.3,11438,1,4,0)
 ;;=4^368.59
 ;;^UTILITY(U,$J,358.3,11438,2)
 ;;=^87408
 ;;^UTILITY(U,$J,358.3,11439,0)
 ;;=368.60^^55^620^67
 ;;^UTILITY(U,$J,358.3,11439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11439,1,3,0)
 ;;=3^Night Blindness
 ;;^UTILITY(U,$J,358.3,11439,1,4,0)
 ;;=4^368.60
 ;;^UTILITY(U,$J,358.3,11439,2)
 ;;=^83350
 ;;^UTILITY(U,$J,358.3,11440,0)
 ;;=368.9^^55^620^114
 ;;^UTILITY(U,$J,358.3,11440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11440,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,11440,1,4,0)
 ;;=4^368.9
 ;;^UTILITY(U,$J,358.3,11440,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,11441,0)
 ;;=369.00^^55^620^109
 ;;^UTILITY(U,$J,358.3,11441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11441,1,3,0)
 ;;=3^Total Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,11441,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,11441,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,11442,0)
 ;;=369.01^^55^620^110
 ;;^UTILITY(U,$J,358.3,11442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11442,1,3,0)
 ;;=3^Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,11442,1,4,0)
 ;;=4^369.01
 ;;^UTILITY(U,$J,358.3,11442,2)
 ;;=^268861
 ;;^UTILITY(U,$J,358.3,11443,0)
 ;;=369.02^^55^620^75
 ;;^UTILITY(U,$J,358.3,11443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11443,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye-NOS
 ;;^UTILITY(U,$J,358.3,11443,1,4,0)
 ;;=4^369.02
 ;;^UTILITY(U,$J,358.3,11443,2)
 ;;=^268862
 ;;^UTILITY(U,$J,358.3,11444,0)
 ;;=369.03^^55^620^74
 ;;^UTILITY(U,$J,358.3,11444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11444,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye Total
 ;;^UTILITY(U,$J,358.3,11444,1,4,0)
 ;;=4^369.03
 ;;^UTILITY(U,$J,358.3,11444,2)
 ;;=^268863
 ;;^UTILITY(U,$J,358.3,11445,0)
 ;;=369.04^^55^620^64
 ;;^UTILITY(U,$J,358.3,11445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11445,1,3,0)
 ;;=3^Near Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,11445,1,4,0)
 ;;=4^369.04
 ;;^UTILITY(U,$J,358.3,11445,2)
 ;;=^268864
 ;;^UTILITY(U,$J,358.3,11446,0)
 ;;=369.06^^55^620^78
 ;;^UTILITY(U,$J,358.3,11446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11446,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,11446,1,4,0)
 ;;=4^369.06
 ;;^UTILITY(U,$J,358.3,11446,2)
 ;;=^268866
 ;;^UTILITY(U,$J,358.3,11447,0)
 ;;=369.07^^55^620^77
 ;;^UTILITY(U,$J,358.3,11447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11447,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Near
 ;;^UTILITY(U,$J,358.3,11447,1,4,0)
 ;;=4^369.07
 ;;^UTILITY(U,$J,358.3,11447,2)
 ;;=^268867
 ;;^UTILITY(U,$J,358.3,11448,0)
 ;;=369.08^^55^620^92
 ;;^UTILITY(U,$J,358.3,11448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11448,1,3,0)
 ;;=3^Profound Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,11448,1,4,0)
 ;;=4^369.08
 ;;^UTILITY(U,$J,358.3,11448,2)
 ;;=^268868
 ;;^UTILITY(U,$J,358.3,11449,0)
 ;;=369.10^^55^620^73
 ;;^UTILITY(U,$J,358.3,11449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11449,1,3,0)
 ;;=3^One Eye-Blind,Oth-Low Vision
 ;;^UTILITY(U,$J,358.3,11449,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,11449,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,11450,0)
 ;;=369.11^^55^620^79
 ;;^UTILITY(U,$J,358.3,11450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11450,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Blind
 ;;^UTILITY(U,$J,358.3,11450,1,4,0)
 ;;=4^369.11
 ;;^UTILITY(U,$J,358.3,11450,2)
 ;;=^268871
 ;;^UTILITY(U,$J,358.3,11451,0)
 ;;=369.12^^55^620^82
 ;;^UTILITY(U,$J,358.3,11451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11451,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,11451,1,4,0)
 ;;=4^369.12
 ;;^UTILITY(U,$J,358.3,11451,2)
 ;;=^268872
 ;;^UTILITY(U,$J,358.3,11452,0)
 ;;=369.13^^55^620^80
 ;;^UTILITY(U,$J,358.3,11452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11452,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Near Total
 ;;^UTILITY(U,$J,358.3,11452,1,4,0)
 ;;=4^369.13
 ;;^UTILITY(U,$J,358.3,11452,2)
 ;;=^268873
 ;;^UTILITY(U,$J,358.3,11453,0)
 ;;=369.14^^55^620^81
 ;;^UTILITY(U,$J,358.3,11453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11453,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Profound
 ;;^UTILITY(U,$J,358.3,11453,1,4,0)
 ;;=4^369.14
 ;;^UTILITY(U,$J,358.3,11453,2)
 ;;=^268874
 ;;^UTILITY(U,$J,358.3,11454,0)
 ;;=369.22^^55^620^102
 ;;^UTILITY(U,$J,358.3,11454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11454,1,3,0)
 ;;=3^Severe Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,11454,1,4,0)
 ;;=4^369.22
 ;;^UTILITY(U,$J,358.3,11454,2)
 ;;=^268882
 ;;^UTILITY(U,$J,358.3,11455,0)
 ;;=369.60^^55^620^6
 ;;^UTILITY(U,$J,358.3,11455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11455,1,3,0)
 ;;=3^Blindness,One Eye Only
 ;;^UTILITY(U,$J,358.3,11455,1,4,0)
 ;;=4^369.60
 ;;^UTILITY(U,$J,358.3,11455,2)
 ;;=^268880
 ;;^UTILITY(U,$J,358.3,11456,0)
 ;;=369.9^^55^620^115
 ;;^UTILITY(U,$J,358.3,11456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11456,1,3,0)
 ;;=3^Visual Loss NOS
 ;;^UTILITY(U,$J,358.3,11456,1,4,0)
 ;;=4^369.9
 ;;^UTILITY(U,$J,358.3,11456,2)
 ;;=^126769
 ;;^UTILITY(U,$J,358.3,11457,0)
 ;;=377.61^^55^620^20
 ;;^UTILITY(U,$J,358.3,11457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11457,1,3,0)
 ;;=3^D/O Pathways w/ Neoplasm
 ;;^UTILITY(U,$J,358.3,11457,1,4,0)
 ;;=4^377.61
 ;;^UTILITY(U,$J,358.3,11457,2)
 ;;=^269241
 ;;^UTILITY(U,$J,358.3,11458,0)
 ;;=379.02^^55^620^68
 ;;^UTILITY(U,$J,358.3,11458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11458,1,3,0)
 ;;=3^Nodular Episcleritis
 ;;^UTILITY(U,$J,358.3,11458,1,4,0)
 ;;=4^379.02
 ;;^UTILITY(U,$J,358.3,11458,2)
 ;;=^269285
 ;;^UTILITY(U,$J,358.3,11459,0)
 ;;=379.07^^55^620^90
 ;;^UTILITY(U,$J,358.3,11459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11459,1,3,0)
 ;;=3^Posterior Scleritis
 ;;^UTILITY(U,$J,358.3,11459,1,4,0)
 ;;=4^379.07
 ;;^UTILITY(U,$J,358.3,11459,2)
 ;;=^269295
 ;;^UTILITY(U,$J,358.3,11460,0)
 ;;=379.92^^55^620^106
 ;;^UTILITY(U,$J,358.3,11460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11460,1,3,0)
 ;;=3^Swelling/Mass of Eye
 ;;^UTILITY(U,$J,358.3,11460,1,4,0)
 ;;=4^379.92
 ;;^UTILITY(U,$J,358.3,11460,2)
 ;;=^269334
 ;;^UTILITY(U,$J,358.3,11461,0)
 ;;=379.93^^55^620^94
 ;;^UTILITY(U,$J,358.3,11461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11461,1,3,0)
 ;;=3^Redness/Discharge of Eye
 ;;^UTILITY(U,$J,358.3,11461,1,4,0)
 ;;=4^379.93
 ;;^UTILITY(U,$J,358.3,11461,2)
 ;;=^104154
 ;;^UTILITY(U,$J,358.3,11462,0)
 ;;=379.99^^55^620^86
 ;;^UTILITY(U,$J,358.3,11462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11462,1,3,0)
 ;;=3^Oth Ill-Defined Eye D/O
 ;;^UTILITY(U,$J,358.3,11462,1,4,0)
 ;;=4^379.99
 ;;^UTILITY(U,$J,358.3,11462,2)
 ;;=^269335
 ;;^UTILITY(U,$J,358.3,11463,0)
 ;;=555.9^^55^620^95
 ;;^UTILITY(U,$J,358.3,11463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11463,1,3,0)
 ;;=3^Regional Enteritis,Unspec
 ;;^UTILITY(U,$J,358.3,11463,1,4,0)
 ;;=4^555.9
 ;;^UTILITY(U,$J,358.3,11463,2)
 ;;=^29356
 ;;^UTILITY(U,$J,358.3,11464,0)
 ;;=696.1^^55^620^93
 ;;^UTILITY(U,$J,358.3,11464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11464,1,3,0)
 ;;=3^Psoriasis
 ;;^UTILITY(U,$J,358.3,11464,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,11464,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,11465,0)
 ;;=709.2^^55^620^39
